https://www.selleckchem.com/pr....oducts/Floxuridine.h
s needs/preferences for younger TBI patients of different racial groups after discharge home from acute hospital care and families. Findings can be used to inform future work. BETTER is among the first TBI transitional care intervention to address needs/preferences for younger TBI patients of different racial groups after discharge home from acute hospital care and families. Findings can be used to inform future work. To present the first real-world data of patients with treatment-resistant depression (TRD) treated with esketamine t
Curtir
Comentario
Compartilhar
